These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34196424)

  • 1. SRSF-1 and microvessel density immunohistochemical analysis by semi-automated tissue microarray in prostate cancer patients with diabetes (DIAMOND study).
    Broggi G; Lo Giudice A; Di Mauro M; Asmundo MG; Pricoco E; Piombino E; Caltabiano R; Morgia G; Russo GI
    Prostate; 2021 Sep; 81(12):882-892. PubMed ID: 34196424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin signaling, androgen receptor and PSMA immunohistochemical analysis by semi-automated tissue microarray in prostate cancer with diabetes (DIAMOND study).
    Broggi G; Lo Giudice A; Di Mauro M; Pricoco E; Piombino E; Ferro M; Caltabiano R; Morgia G; Russo GI
    Transl Res; 2021 Dec; 238():25-35. PubMed ID: 34314871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor overexpression in prostate cancer in type 2 diabetes.
    Lutz SZ; Hennenlotter J; Scharpf MO; Sailer C; Fritsche L; Schmid V; Kantartzis K; Wagner R; Lehmann R; Berti L; Peter A; Staiger H; Fritsche A; Fend F; Todenhöfer T; Stenzl A; Häring HU; Heni M
    Mol Metab; 2018 Feb; 8():158-166. PubMed ID: 29249638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
    Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
    Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of microvessel density and proliferation in prostate cancer core biopsy.
    Matic SD; Rakocevic MS; Jocic TT; Todorovic MS; Vuckovic LM; Jancic SA; Knezevic MG
    J BUON; 2017; 22(3):757-765. PubMed ID: 28730786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of microvessel density in prostate cancer: a tissue microarray study.
    Erbersdobler A; Isbarn H; Dix K; Steiner I; Schlomm T; Mirlacher M; Sauter G; Haese A
    World J Urol; 2010 Dec; 28(6):687-92. PubMed ID: 19714336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki-67 Immunostaining and its Correlation with Microvessel Density in Patients with Mutiple Myeloma.
    Himani B; Meera S; Abhimanyu S; Usha R
    Asian Pac J Cancer Prev; 2016; 17(5):2559-64. PubMed ID: 27268630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
    Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
    Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
    Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.
    Gyftopoulos K; Vourda K; Sakellaropoulos G; Perimenis P; Athanasopoulos A; Papadaki E
    Urol Int; 2011; 87(4):464-9. PubMed ID: 21912077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of the impact of ischemic change in benign prostatic hyperplasia.
    Jin Cho W; Pyo JS
    Pathol Res Pract; 2020 Jan; 216(1):152694. PubMed ID: 31734054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive values of vascular endothelial growth factor and microvessel-density levels in initial biopsy for prostate cancer.
    Kervancioglu E; Kosan M; Erinanc H; Gonulalan U; Oguzulgen AI; Coskun EZ; Ozkardes H
    Kaohsiung J Med Sci; 2016 Feb; 32(2):74-9. PubMed ID: 26944325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma.
    Cao Y; Zhang ZL; Zhou M; Elson P; Rini B; Aydin H; Feenstra K; Tan MH; Berghuis B; Tabbey R; Resau JH; Zhou FJ; Teh BT; Qian CN
    Cancer; 2013 Jan; 119(2):313-24. PubMed ID: 22811049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer.
    Goltz D; Montani M; Braun M; Perner S; Wernert N; Jung K; Dietel M; Stephan C; Kristiansen G
    Pathology; 2015 Dec; 47(7):629-36. PubMed ID: 26517642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of microvessel density with nuclear pleomorphism, mitotic count and vascular invasion in breast and prostate cancers at preclinical and clinical levels.
    Muhammadnejad S; Muhammadnejad A; Haddadi M; Oghabian MA; Mohagheghi MA; Tirgari F; Sadeghi-Fazel F; Amanpour S
    Asian Pac J Cancer Prev; 2013; 14(1):63-8. PubMed ID: 23534805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance.
    Jhavar S; Bartlett J; Kovacs G; Corbishley C; Dearnaley D; Eeles R; Khoo V; Huddart R; Horwich A; Thompson A; Norman A; Brewer D; Cooper CS; Parker C
    Prostate Cancer Prostatic Dis; 2009; 12(2):143-7. PubMed ID: 18762814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging proliferation of ¹⁸F-FLT PET/CT correlated with the expression of microvessel density of tumour tissue in non-small-cell lung cancer.
    Yang W; Zhang Y; Fu Z; Sun X; Mu D; Yu J
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1289-96. PubMed ID: 22581165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of microvessel density, androgen receptor, p53 and HER-2/neu expression and Gleason score in prostate cancer . preliminary results and therapeutic implications.
    Mydlo JH; Kral JG; Volpe M; Axotis C; Macchia RJ; Pertschuk LP
    Eur Urol; 1998; 34(5):426-32. PubMed ID: 9803006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an epithelial plasticity biomarker panel in men with localized prostate cancer.
    Armstrong AJ; Healy P; Halabi S; Vollmer R; Lark A; Kemeny G; Ware K; Freedland SJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):40-5. PubMed ID: 26458958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.